Tsumura & Co. (4540.T)

JPY 4759.0

(-0.69%)

Operating Expenses Summary of Tsumura & Co.

  • Tsumura & Co.'s latest annual operating expenses in 2023 was 48.8 Billion JPY , up 3.03% from previous year.
  • Tsumura & Co.'s latest quarterly operating expenses in 2024 Q1 was 12.25 Billion JPY , down -4.87% from previous quarter.
  • Tsumura & Co. reported a annual operating expenses of 47.36 Billion JPY in annual operating expenses 2022, up 7.43% from previous year.
  • Tsumura & Co. reported a annual operating expenses of 44.08 Billion JPY in annual operating expenses 2021, down -20.63% from previous year.
  • Tsumura & Co. reported a quarterly operating expenses of 12 Billion JPY for 2023 Q1, down -4.15% from previous quarter.
  • Tsumura & Co. reported a quarterly operating expenses of 12.88 Billion JPY for 2023 Q4, up 10.1% from previous quarter.

Annual Operating Expenses Chart of Tsumura & Co. (2023 - 2003)

Historical Annual Operating Expenses of Tsumura & Co. (2023 - 2003)

Year Operating Expenses Operating Expenses Growth
2023 48.8 Billion JPY 3.03%
2022 47.36 Billion JPY 7.43%
2021 44.08 Billion JPY -20.63%
2020 55.54 Billion JPY 3.59%
2019 53.62 Billion JPY 1.3%
2018 52.93 Billion JPY 3.34%
2017 51.22 Billion JPY 3.45%
2016 49.51 Billion JPY 3.71%
2015 47.74 Billion JPY -2.74%
2014 49.08 Billion JPY 0.57%
2013 48.8 Billion JPY 4.77%
2012 46.58 Billion JPY 5.23%
2011 44.27 Billion JPY 1.1%
2010 43.78 Billion JPY 0.72%
2009 43.47 Billion JPY -2.31%
2008 44.5 Billion JPY -6.05%
2007 47.36 Billion JPY 2.35%
2006 46.28 Billion JPY 0.72%
2005 45.95 Billion JPY -0.86%
2004 46.35 Billion JPY 2.32%
2003 45.29 Billion JPY 0.0%

Peer Operating Expenses Comparison of Tsumura & Co.

Name Operating Expenses Operating Expenses Difference
Pharma Foods International Co., Ltd. 43.63 Billion JPY -11.827%
Takeda Pharmaceutical Company Limited 2618.18 Billion JPY 98.136%
Sumitomo Pharma Co., Ltd. 542.17 Billion JPY 90.999%
Shionogi & Co., Ltd. 197.62 Billion JPY 75.307%
Wakamoto Pharmaceutical Co.,Ltd. 3.73 Billion JPY -1206.084%
Nippon Shinyaku Co., Ltd. 65.63 Billion JPY 25.645%
Kaken Pharmaceutical Co., Ltd. 29.02 Billion JPY -68.125%
Eisai Co., Ltd. 533.01 Billion JPY 90.844%
Morishita Jintan Co., Ltd. 5.28 Billion JPY -823.892%
Hisamitsu Pharmaceutical Co., Inc. 65.8 Billion JPY 25.84%
Mochida Pharmaceutical Co., Ltd. 46.26 Billion JPY -5.475%
Fuso Pharmaceutical Industries,Ltd. 11.55 Billion JPY -322.401%
Nippon Chemiphar Co., Ltd. 8.23 Billion JPY -492.809%
Kissei Pharmaceutical Co., Ltd. 33.32 Billion JPY -46.441%
Torii Pharmaceutical Co., Ltd. 19.53 Billion JPY -149.782%
Towa Pharmaceutical Co., Ltd. 63.73 Billion JPY 23.434%
Fuji Pharma Co., Ltd. 12.65 Billion JPY -285.557%
Zeria Pharmaceutical Co., Ltd. 40.46 Billion JPY -20.599%
KYORIN Holdings, Inc. 45.39 Billion JPY -7.501%
Taiko Pharmaceutical Co.,Ltd. 4.15 Billion JPY -1073.924%
Daito Pharmaceutical Co.,Ltd. 5.94 Billion JPY -720.858%
SymBio Pharmaceuticals Limited 5.22 Billion JPY -834.386%
MedRx Co., Ltd 959 Million JPY -4988.634%
Mizuho Medy Co.,Ltd. 2.87 Billion JPY -1598.142%
Solasia Pharma K.K. 1.47 Billion JPY -3206.233%
Modalis Therapeutics Corporation 2.37 Billion JPY -1958.494%
ASKA Pharmaceutical Holdings Co.,Ltd. 24.16 Billion JPY -101.945%
Sawai Group Holdings Co., Ltd. 35.43 Billion JPY -37.725%
Cyfuse Biomedical K.K. 735.18 Million JPY -6537.821%
Toho Holdings Co., Ltd. 99.81 Billion JPY 51.111%
Koa Shoji Holdings Co.,Ltd. 2.25 Billion JPY -2061.887%